T1	Pharmacological_substance 10 19	Captopril
N1000 	Reference T1 MeSH:D002216	Captopril
T2	Disorder 28 67	pulmonary infiltrates with eosinophilia
N1 	Reference T2 UMLS:C0034068	pulmonary infiltrates with eosinophilia
T3	Disorder 86 110	congenital heart disease
N2 	Reference T3 UMLS:C0152021	congenital heart disease
T4	Disorder 156 180	congenital heart disease
N3 	Reference T4 UMLS:C0152021	congenital heart disease
T5	Pharmacological_substance 199 208	captopril
N1001 	Reference T5 MeSH:D002216	captopril
T6	Disorder 286 325	pulmonary infiltrates with eosinophilia
N4 	Reference T6 UMLS:C0034068	pulmonary infiltrates with eosinophilia
T7	Disorder 512 556	peripheral eosinophilia without leukocytosis
T9	Pharmacological_substance 578 587	captopril
N1002 	Reference T9 MeSH:D002216	captopril
T10	Pharmacological_substance 610 618	steroids
N1003 	Reference T10 MeSH:D013256	steroids
T11	Disorder 665 677	eosinophilia
N5 	Reference T11 UMLS:C1636667	eosinophilia
N6 	Reference T11 UMLS:C0014457	eosinophilia
T12	Subject 71 80	an infant
T14	Subject 133 142	an infant
T17	Disorder 371 381	rhinorrhea
N7 	Reference T17 UMLS:C1260880	rhinorrhea
T18	Disorder 383 395	poor feeding
N8 	Reference T18 UMLS:C0576456	poor feeding
T19	Disorder 401 425	decreased activity level
N9 	Reference T19 UMLS:C0375741	decreased activity level
N10 	Reference T19 UMLS:C0375741	decreased activity level
T20	Disorder 682 708	radiographic abnormalities
N11 	Reference T20 UMLS:C0000768	radiographic abnormalities
T21	Disorder 449 478	diffuse pulmonary infiltrates
T23	Coreferring_mention 327 338	The patient
T24	Disorder 624 638	symptomatology
T28	Coreferring_mention 427 430	She
T8	Coreferring_mention 661 664	her
